Trial · NCT04223193
Results by group150
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 150
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts II and III Combined Score | Placebo | -1.2 | Standard Error 0.89 | score on a scale | |
| Change From Baseline in the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts II and III Combined Score | Tavapadon | -10.3 | Standard Error 0.99 | score on a scale | |
| Change From Baseline in the MDS-UPDRS Part II Score | Placebo | 0.0 | Standard Error 0.30 | score on a scale | |
| Change From Baseline in the MDS-UPDRS Part II Score | Tavapadon | -1.5 | Standard Error 0.33 | score on a scale | |
| Percentage of Responders With Much Improved or Very Much Improved on Participant Global Impression of Change (PGIC) | Placebo | 25 | Participants | ||
| Percentage of Responders With Much Improved or Very Much Improved on Participant Global Impression of Change (PGIC) | Tavapadon | 46 | Participants | ||
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 5 | -2.1 | Standard Error 0.58 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 5 | -5.5 | Standard Error 0.63 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 8 | -2.4 | Standard Error 0.64 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 8 | -8.5 | Standard Error 0.69 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 11 | -2.3 | Standard Error 0.71 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 11 | -9.5 | Standard Error 0.77 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 14 | -2.2 | Standard Error 0.76 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 14 | -10.3 | Standard Error 0.84 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 18 | -2.2 | Standard Error 0.85 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 18 | -10.0 | Standard Error 0.93 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 22 | -1.3 | Standard Error 0.82 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 22 | -10.1 | Standard Error 0.92 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Placebo | Week 26 | -1.2 | Standard Error 0.89 | score on a scale |
| Change From Baseline in the MDS-UPDRS Parts II and III Combined Score | Tavapadon | Week 26 | -10.3 | Standard Error 0.99 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04223193/results